Hussain I. Saba

4.2k citations

45 papers · 3.2k indexed · 2 hit papers · h-index 20

Hematology top 0.5%
- Acute Myeloid Leukemia Research 15
- Blood Coagulation and Thrombosis Mechanisms 5
Genetics top 2%
- Hemoglobinopathies and Related Disorders 5
Oncology top 5%
- Cutaneous Melanoma Detection and Management 7
Molecular Biology top 5%
- Epigenetics and DNA Methylation 5
Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management 6
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 5
Pulmonary and Respiratory Medicine
- Blood properties and coagulation 3

Co-authors: Jean‐Pierre J. Issa Hagop M. Kantarjian Farhad Ravandi Lanlan Shen John F. DiPersio Azra Raza Carlos de Castro Lozano C Rosenfeld
Cited by: Hematology Genetics Oncology
Partner nations: United States Pakistan

In The Last Decade

Hussain I. Saba

45 papers receiving 3.1k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2006 Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia
2006 Decitabine improves patient outcomes in myelodysplastic syndromes

Peers

Countries citing papers authored by Hussain I. Saba

Since Specialization

Citations

This map shows the geographic impact of Hussain I. Saba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hussain I. Saba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hussain I. Saba more than expected).

Fields of papers citing papers by Hussain I. Saba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hussain I. Saba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hussain I. Saba. The network helps show where Hussain I. Saba may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hussain I. Saba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hussain I. Saba Line = papers co-authored together Hussain I. Saba links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Combined treatment with lenalidomide and epoetin alfa in lower-risk patients with myelodysplastic syndrome Rami S. Komrokji,Jeffrey E. Lancet,Arlene S. Swern,Nianhang Chen,Jennifer Paleveda,Richard M. Lush,Hussain I. Saba,Alan F. List	2012	47
2	Phase I Combination Trial of Lenalidomide and Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes Mikkael A. Sekeres,Alan F. List,David Cuthbertson,Ronald Paquette,Rebecca Ganetsky,D Latham,Katarina Paulic,Manuel Afable,Hussain I. Saba,Thomas P. Loughran,Jaroslaw P. Maciejewski	2010	86
3	Disseminated Intravascular Coagulation (DIC) in Cancer Hussain I. Saba,Genevieve A. Morelli,Rashid I. Saba	2009	12
4	Decitabine improves patient outcomes in myelodysplastic syndromesbreakdown → Hagop M. Kantarjian,Jean‐Pierre J. Issa,C Rosenfeld,John M. Bennett,Maher Albitar,John F. DiPersio,Virginia M. Klimek,James L. Slack,Carlos de Castro Lozano,Farhad Ravandi,Richard E. Helmer,Lanlan Shen,Stephen D. Nimer,Richard D. Leavitt,Azra Raza,Hussain I. Saba	2006	1139
5	Decitabine in Myelodysplastic Syndromes Hussain I. Saba,Pierre W. Wijermans	2005	19
6	Thromboembolism preceding cancer: A correlation study Hussain I. Saba,Farrah K. Khalil,Genevieve A. Morelli,Philip Foulis	2003	21
7	Acute myeloid leukemia mimicking primary testicular neoplasm. Presentation of a case with review of literature Laura McIlwain,Lubomir Sokol,Lynn C. Moscinski,Hussain I. Saba	2003	18
8	Metastatic Seminoma Simulating Malignant Lymphoma in an HIV Infected Hemophiliac José I. Diaz,Santo V. Nicosia,Jenö E. Szakács,Julio M. Pow‐Sang,Hussain I. Saba	1996	3
9	Myelodysplastic syndromes in the elderly: The role of growth factors in management Hussain I. Saba	1996	18
10	Treatment of Bleeding in Hereditary Hemorrhagic Telangiectasia with Aminocaproic Acid Hussain I. Saba,Genevieve A. Morelli,Luis A. Logrono	1994	68
11	Computer Database for Melanoma: A Clinical Management and Research Tool to Ensure Continuous Quality Assessment Douglas S. Reintgen,C. Wayne Cruse,Kenneth R. Schroer,Frank Glass,Hussain I. Saba,Chris Puleo,Jeff King,Claudia G. Berman,Laura Hannon,Charles Cox	1993	4
12	Polycythemia as a Complication of Human Immunodeficiency Virus Infection T. Bradley Edwards,Robert P. Nelson,Oscar Ballester,Hussain I. Saba,Richard F. Lockey	1993	2
13	Treatment of Stage IV Malignant Melanoma with Dacarbazine, Carmustine, Cisplatin, and Tamoxifen Regimens: A University of South Florida and H. Lee Moffitt Melanoma Center Study Hussain I. Saba,C. Wayne Cruse,Karen Wells,Christoph Klein,Douglas S. Reintgen	1992	16
14	Adjuvant Chemotherapy in Malignant Melanoma Using Dacarbazine, Carmustine, Cisplatin, and Tamoxifen: A University of South Florida and H. Lee Moffitt Melanoma Center Study Hussain I. Saba,C. Wayne Cruse,Karen Wells,Carolyn J Klein,Douglas S. Reintgen	1992	10
15	Metastatic Melanoma with an Unknown Primary Jim C. Norman,C. Wayne Cruse,Karen Wells,Hussain I. Saba,Douglas S. Reintgen	1992	25
16	The Evaluation of Putative Tumor Markers for Malignant Melanoma Douglas S. Reintgen,C. Wayne Cruse,Karen Wells,Hussain I. Saba,Peter J. Fabri	1992	14
17	Isolated Limb Perfusion for Recurrent Melanoma of the Extremity Douglas S. Reintgen,C. Wayne Cruse,Karen Wells,Hussain I. Saba,Craig L. Slingluff	1992	14
18	Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma Jim C. Norman,C. Wayne Cruse,Carmen Espinosa,Charles Cox,Claudia G. Berman,Robert A. Clark,Hussain I. Saba,Karen Wells,Douglas S. Reintgen	1991	183
19	Serum prostacyclin binding and half-life in the umbilical circulation William F. O’Brien,Robert A. Knuppel,Hussain I. Saba,Raymond R. Benoit,Anita Bruce	1988	8
20	Heparin Neutralization of PGI ₂ : Effects Upon Platelets Hussain I. Saba,Sabiha R. Saba,C Blackburn,Robert C. Hartmann,Reginald G. Mason	1979	41

About Hussain I. Saba

Hussain I. Saba is a scholar working on Hematology, Internal Medicine and Genetics, having authored 45 papers that have together received 3.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (15 papers), Cutaneous Melanoma Detection and Management (7 papers), Venous Thromboembolism Diagnosis and Management (6 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers), Epigenetics and DNA Methylation (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Hemoglobinopathies and Related Disorders (5 papers) and Blood properties and coagulation (3 papers). The work is most often cited by research in Hematology (1.8k citations), Genetics (595 citations) and Oncology (692 citations). Hussain I. Saba has collaborated with scholars based in United States and Pakistan. Frequent co-authors include Jean‐Pierre J. Issa, Hagop M. Kantarjian, Farhad Ravandi, Lanlan Shen, John F. DiPersio, Azra Raza, Carlos de Castro Lozano, C Rosenfeld, James L. Slack and Virginia M. Klimek.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact